Trademark: 86364754
Word
SOCTEC
Status
Registered
Status Code
700
Status Date
Tuesday, June 19, 2018
Serial Number
86364754
Registration Number
5494819
Registration Date
Tuesday, June 19, 2018
Mark Type
4000
Filing Date
Tuesday, August 12, 2014
Published for Opposition
Tuesday, April 3, 2018

Trademark Owner History
Jagotec AG - Original Registrant

Classifications
5 Pharmaceuticals having a self-orienting effect, namely, orally delivered pharmaceuticals with modified time release into the gastrointestinal system; gastro retentive pharmaceuticals; self orienting pharmaceuticals in the form of capsules, namely, capsules consisting of segments of varied functions and absorption rates, resulting in controlled release into the gastrointestinal tract; Gastrointestinal drug delivery preparations for medical, surgical and biological purposes; chronotherapy-focused tablets, analgesics; Medicines for treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; medicinal preparations for treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; capsules for the release of colonic drug delivery; pharmaceuticals for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders, medical and veterinary preparations for body slimming purposes; capsules, suppositories, tablets and pills for pharmaceutical, medical and veterinary purposes for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pre-filled vials containing medical diagnostic reagents; exclude goods being related to the treatment of respiratory diseases
44 Medical services; veterinary services; hygienic care for human beings or animals; medical analysis for the diagnosis and treatment of persons treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pharmacy advice; provision of information relating to medical, surgical and veterinary matters online from a computer database or over the Internet; exclude services in the field of inhalation technology
10 inhalers for medical purposes; injection apparatus, instruments and devices, namely, medical apparatus in the nature of an infusion injection device for administering drugs; apparatus, instruments and devices, namely, automated drug delivery systems for storing and dispensing medical, surgical and veterinary preparations, capsules, powders, tablets and pills; instruments and apparatus for the administration of self-orientation therapy and prophylaxis preparations and substances, namely, gastrointestinal drug delivery systems, syringes and fluid injectors for medical purposes; exclude goods being related to the treatment of respiratory diseases
42 Scientific and technological services, namely, custom design exclusively in the pharmaceuticals and medical fields; design services exclusively in the pharmaceuticals and medical fields; drug development and custom design of pharmaceuticals and medical goods; exclude services in the field of inhalation technology
The word(s) "SOCTEC" has no meaning in a foreign language.

Trademark Events
Jun 19, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 19, 2018
Registered-Principal Register
Apr 29, 2018
Teas Change Of Correspondence Received
Apr 3, 2018
Official Gazette Publication Confirmation E-Mailed
Apr 3, 2018
Published For Opposition
Mar 14, 2018
Notification Of Notice Of Publication E-Mailed
Feb 26, 2018
Law Office Publication Review Completed
Feb 13, 2018
Approved For Pub - Principal Register
Feb 13, 2018
Examiner's Amendment Entered
Feb 12, 2018
Notification Of Examiners Amendment E-Mailed
Feb 12, 2018
Examiners Amendment E-Mailed
Feb 12, 2018
Examiners Amendment -Written
Nov 27, 2017
Notification Of Non-Final Action E-Mailed
Nov 27, 2017
Non-Final Action E-Mailed
Nov 27, 2017
Non-Final Action Written
Nov 3, 2017
Teas/Email Correspondence Entered
Nov 3, 2017
Correspondence Received In Law Office
Nov 2, 2017
Teas Response To Suspension Inquiry Received
Oct 31, 2017
Notification Of Letter Of Suspension E-Mailed
Oct 31, 2017
Letter Of Suspension E-Mailed
Oct 31, 2017
Suspension Letter Written
Oct 31, 2017
Previous Allowance Count Withdrawn
Oct 31, 2017
Case Returned To Examination
Oct 31, 2017
Notice Of Allowance Cancelled
May 9, 2017
Noa E-Mailed - Sou Required From Applicant
Mar 14, 2017
Official Gazette Publication Confirmation E-Mailed
Mar 14, 2017
Published For Opposition
Feb 22, 2017
Notification Of Notice Of Publication E-Mailed
Feb 7, 2017
Law Office Publication Review Completed
Jan 31, 2017
Approved For Pub - Principal Register
Jan 31, 2017
Examiner's Amendment Entered
Jan 31, 2017
Notification Of Examiners Amendment E-Mailed
Jan 31, 2017
Examiners Amendment E-Mailed
Jan 31, 2017
Examiners Amendment -Written
Aug 15, 2016
Notification Of Priority Action E-Mailed
Aug 15, 2016
Priority Action E-Mailed
Aug 15, 2016
Priority Action Written
Jul 20, 2016
Suspension Checked ¿ To Attorney For Action
Jul 14, 2016
Teas/Email Correspondence Entered
Jul 14, 2016
Correspondence Received In Law Office
Jul 14, 2016
Teas Response To Suspension Inquiry Received
Jan 20, 2016
Notification Of Letter Of Suspension E-Mailed
Jan 20, 2016
Letter Of Suspension E-Mailed
Jan 20, 2016
Suspension Letter Written
Dec 29, 2015
Suspension Checked ¿ To Attorney For Action
Jun 25, 2015
Notification Of Letter Of Suspension E-Mailed
Jun 25, 2015
Letter Of Suspension E-Mailed
Jun 25, 2015
Suspension Letter Written
Jun 8, 2015
Teas/Email Correspondence Entered
Jun 8, 2015
Correspondence Received In Law Office
Jun 1, 2015
Assigned To Lie
May 26, 2015
Teas Response To Office Action Received
Nov 26, 2014
Notification Of Non-Final Action E-Mailed
Nov 26, 2014
Non-Final Action E-Mailed
Nov 26, 2014
Non-Final Action Written
Nov 25, 2014
Assigned To Examiner
Aug 21, 2014
New Application Office Supplied Data Entered
Aug 15, 2014
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24